Associate Professor Tao Yang MBBS, MSc, PhD, FRCPA, is a senior staff specialist in Anatomical Pathology and Molecular Pathology at SydPath, and a conjoint Associate Professor at the School of Medicine of Western Sydney University. He is a lead pathologist in gastrointestinal, pancreatobiliary and liver pathology as well as molecular pathology. His areas of sub-specialty expertise also include renal pathology, gynaecological pathology and cytopathology. Prior to his appointment at SydPath, he was the Head of Molecular Pathology at Liverpool Hospital. He received his training at both Royal Prince Alfred Hospital and Liverpool Hospital.
In 2007, he obtained his PhD in Molecular and Cellular Pathology from the University of Queensland at the Centre for Kidney Disease Research, in the field of gene therapy using lentiviral-mediated vectors and RNA interference to limit renal fibrosis. He was among the first pathologists in Australia to receive the Certification for Genetic/Genomic Testing from the Royal College of Pathologists of Australasia in 2019. He is currently a designated pathologist for the Division of Cancer Genetics at SydPath, specialising in next generation sequencing and fluorescence in situ hybridisation testing on solid tumours.
A/Prof Yang is passionate about fostering the next generation of doctors and specialists. He supervises PhD students at Western Sydney University and teaches senior medical students at the University of New South Wales. He works as a thesis examiner and arbiter for MBBS Honours students at Western Sydney University, a PhD examiner for University of Sydney and a panel examiner for FRCPA-qualifying exams at the Royal College of Pathologists of Australasia.
As a recipient of both NHMRC and Cancer Council of New South Wales grants, his research focuses on molecular mechanisms of cancers and their precursors. He is currently the lead pathologist for two NHMRC Ideas Grant projects: Improving the Diagnosis of Barrett’s Oesophagus with Dysplasia, and High-fidelity tumouroids: accelerating next generation personalised medicine. A/Prof Yang is also the Chair of the SydPath Research Committee.